InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

CTAD 2024 brings together leaders from the Alzheimer's research community, including pharmaceutical companies, academic ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

Listen to episode nine, “Executing Clinical Research in Dementia with Lewy Bodies (DLB)” on the Conversations tab of the Cognition website. This conversation is presented in 3 Chapters: 1) Comparing ...

Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...

Chicken, peas and mashed potato might seem like a fairly ordinary meal to most people, but, for Bradley Phelps, that was the ...

New research has revealed that a class of proteins possesses a previously unknown cell-protecting function that could be ...

A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a ...

A group of major research organizations published cutting edge research that uses computer modeling to make a first of it's ...

Although some people might benefit from medications, lifestyle behaviors that can help reduce stroke risk include healthy ...

The new study, lauded as “a leap beyond previous studies," found that severe infections can lead to long-term cognitive problems. In other news about the brain, the military has begun testing new ways ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...